Palatin Technologies
PTN
#10835
Rank
ยฃ11.51 M
Marketcap
ยฃ6.47
Share price
-0.58%
Change (1 day)
N/A
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2026 (TTM): -ยฃ4.62 Million

According to Palatin Technologies's latest financial reports the company's current earnings are ยฃ12.88 Million. In 2025 the company made an earning of -ยฃ7.28 Million, an increase over its 2024 earnings that were of -ยฃ20.38 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ4.62 Million-36.59%
2025 -ยฃ7.28 Million-64.29%
2024 -ยฃ20.38 Million-16.9%
2023 -ยฃ24.53 Million5.99%
2022 -ยฃ23.14 Million-13.7%
2021 -ยฃ26.82 Million33.25%
2020 -ยฃ20.13 Million-172.11%
2019 ยฃ27.9 M2352.33%
2018 ยฃ1.13 M-94.13%
2017 ยฃ19.38 M-154.92%
2016 -ยฃ35.31 Million3.67%
2015 -ยฃ34.06 Million878%
2014 -ยฃ3.49 Million-72.64%
2013 -ยฃ12.73 Million-33.11%
2012 -ยฃ19.03 Million77.71%
2011 -ยฃ10.71 Million
2003 -ยฃ18.13 Million29.93%
2002 -ยฃ13.96 Million36.18%
2001 -ยฃ10.25 Million
1999 -ยฃ8.51 Million6.04%
1998 -ยฃ8.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ19.82 B-419,974.84%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ10.84 B-229,711.05%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
ยฃ0.61 B-13,209.87%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-ยฃ8.14 Million 72.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
ยฃ0.18 B-4,011.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-ยฃ89.01 Million 1,784.89%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
ยฃ0.10 B-2,384.53%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-ยฃ22.31 Million 372.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-ยฃ41.97 Million 788.76%๐Ÿ‡บ๐Ÿ‡ธ USA